Aclaris Therapeutics
ACRS
ACRS
110 hedge funds and large institutions have $707M invested in Aclaris Therapeutics in 2017 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.71% more ownership
Funds ownership: 84% → 90.71% (+6.7%)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
110
Holding in Top 10
5
Calls
$3.28M
Puts
–
Top Buyers
| 1 | +$35.4M | |
| 2 | +$29M | |
| 3 | +$23.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.7M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$11.9M |
Top Sellers
| 1 | -$22.4M | |
| 2 | -$12.7M | |
| 3 | -$12.7M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$12.7M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$8.03M |